publication venue for
- A systematic review of neuropsychological and psychiatric sequelae of COVID-19: Implications for treatment. 34:420-433. 2021
- Technology-driven science: will it advance treatment of schizophrenia going into the second decade of the 21st century?. 24. 2011
- Schizophrenia and substance abuse: Is schizophrenia forgotten?. 30. 2017
- How precise is precision medicine for schizophrenia?. 29. 2016
- The problem of substance abuse in people with schizophrenia.. 28. 2015
- Encouraging a new generation of researchers in a time of limited resources.. 26. 2013
- Should a 'psychosis risk syndrome' be a separate diagnosis in DSM-5?. 25. 2012
- Schizophrenia treatment: entering a new decade.. 23. 2010
- Has there been progress in schizophrenia research and treatment for all peoples during 2008? Existing disparities in mental healthcare and research?. 22. 2009
- Advances in the pathophysiology of bipolar disorder. 2022
- Pharmacotherapy of eating disorders. 2017
- Cognitive decline associated with anesthesia and surgery in the elderly: does this contribute to dementia prevalence? 2017
- Schizophrenia: when clozapine fails. 2015
- Understanding and translating the knowledge about placebo effects: the contribution of psychology. 2014
- From DSM-IV to DSM-5: changes to eating disorder diagnoses. 2013
- Alternative pharmacologic targets for the treatment of schizophrenia: results from phase I and II trials. 2013
- Antipsychotics in the early stage of development. 2009